0 results available. Select is focused ,type to refine list, press Down to open the menu,
H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and inter...
The following section summarizes insights on H. Lundbeck A/S's EBITDA Margin:
We've identified the following companies as similar to H. Lundbeck A/S because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EBITDA Margin in the efficiency category include:
Earnings before interest, taxes, depreciation and amortization (EBITDA) expressed as a percent of revenue.
The ebitda margin measures a company’s ebitda as a percentage of the revenue. The formula to calculate ebitda margin and an example calculation for H. Lundbeck’s trailing twelve months is outlined below:
EBITDA Margin = EBITDA / Total Revenue
28.1% = 827.8 M / 2.95 B
The tables below summarizes H. Lundbeck’s performance over the last five years:
| Fiscal Year | EBITDA | Revenue | Margin |
|---|---|---|---|
| 2020-12-31 | 644.4 M | 2.374 B | 27.1% |
| 2021-12-31 | 519.7 M | 2.191 B | 23.7% |
| 2022-12-31 | 614.5 M | 2.453 B | 25.0% |
| 2023-12-31 | 739.6 M | 2.671 B | 27.7% |
| 2024-12-31 | 827.8 M | 2.95 B | 28.1% |
The tables below summarizes H. Lundbeck’s performance over the last four quarters:
| Quarter Ending | EBITDA | Revenue | Margin |
|---|---|---|---|
| 2024-03-31 | 234.1 M | 708.9 M | 33.0% |
| 2024-06-30 | 197.2 M | 731.1 M | 27.0% |
| 2024-09-30 | 191.5 M | 767.5 M | 25.0% |
| 2024-12-31 | 203.9 M | 743 M | 27.4% |
You can read more about EBITDA here.
The chart above depicts the distribution of ebitda margin for companies operating in the Healthcare sector in the Developed economic region. Over 1,920 companies were considered in this analysis, and 1,848 had meaningful values. The average ebitda margin of companies in the sector is -1,035.5% with a standard deviation of 4,163.8%.
H. Lundbeck A/S's EBITDA Margin of 28.1% ranks in the 93.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,924 |
| Included Constituents | 1,848 |
| Min | -46,520.8% |
| Max | 58.4% |
| Median | -9.5% |
| Mean | -1,035.5% |
| Standard Deviation | 4,163.8% |
You can find companies with similar ebitda margin using this stock screener.